Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcome of Esmolol Potassium Cardioplegia Compared to Potassium Cardioplegia in Patients With Solitary Valvular Disease; Randomized Controlled Study

NCT04306913 is registered in ClinicalTrials.gov with Kasr El Aini Hospital as lead sponsor.

NCT NCT04306913
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04306913 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcome of Esmolol Potassium Cardioplegia Compared to Potassium Cardioplegia in Patients With Solitary Valvular Disease; Randomized Controlled Study
Lead sponsor
Kasr El Aini Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
April 30, 2020
Completion date
September 30, 2020
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardioplegia solution adverse reaction